Contents

Reviews on Recent Clinical Trials, Volume 10 - Number 2


Editorial


Role of Anti-HER-2 Therapies in the Neo-Adjuvant Setting: Is Complete Pathological Response a Solid Surrogate?

, 10(2): 82 - 89

Matias E. Valsecchi and Enrique Diaz-Canton


DOI: 10.2174/157488711002150714134341



Anti-Hormonal Therapies for Premenopausal Patients – What did we Learn from the TEXT/SOFT Trials?

, 10(2): 90 - 100

Matias E. Valsecchi, Gonzalo Recondo, Maximo de la Vega, Martin Greco, Gonzalo Recondo and Enrique Diaz Canton


DOI: 10.2174/157488711002150714134611



Role of Carboplatin in the Treatment of Triple Negative Early- Stage Breast Cancer

, 10(2): 101 - 110

Matias E. Valsecchi, Gerrit Kimmey, Arvinder Bir and Damian Silbermins


DOI: 10.2174/1574887110666150624101343



Current Indications for Implantable Cardioverter Defibrillators in Non-Ischemic Cardiomyopathies and Channelopathies

, 10(2): 111 - 127

Esteban Gonzalez-Torrecilla, Angel Arenal, Felipe Atienza, Tomas Datino, Loreto Bravo, Pablo Ruiz, Pablo Avila and Francisco Fernandez-Aviles


DOI: 10.2174/1574887110666150407104312




The ModifiedGlasgow Prognostic Score and Survival in Colorectal Cancer: A Pooled Analysis of the Literature

, 10(2): 135 - 141

Fausto Petrelli, Sandro Barni, Andrea Coinu, Paola Bertocchi, Karen Borgonovo, Mary Cabiddu, Mara Ghilardi and Alberto Zaniboni


DOI: 10.2174/1574887110666150317121413



Gemcitabine Plus Nab-Paclitaxel as Second-Line and Beyond Treatment for Metastatic Pancreatic Cancer: a Single Institution Retrospective Analysis

, 10(2): 142 - 145

Paola Bertocchi, Chiara Abeni, Fausto Meriggi, Luigina Rota, Anna Rizzi, Brunella Di Biasi, Francesca Aroldi, Chiara Ogliosi, Giordano Savelli, Edoardo Rosso and Alberto Zaniboni


DOI: 10.2174/1574887110666150417115303




Management of Acute Diarrhea: A Study on Community Pharmacists’ Attitudes in Iran

, 10(2): 155 - 160

Golnaz Vaseghi, Azadeh Eshraghi, Neda Eslami, Moein Masjedi, Maryam Mehrpooya and Nazanin Eshraghi


DOI: 10.2174/1574887110666150416104745



The Efficacy and Safety of Eberconazole Nitrate 1% and Mometasone Furoate 0.1% w/w Cream in Subjects with Inflamed Cutaneous Mycoses

, 10(2): 161 - 170

Rao Gnaneshwar, A. S. Kumar, Fernandes Carol, Jacintha Martis, H. R. Jerajani, Maria Kuruvila, M. S. Latha and Binny Krishnankutty


DOI: 10.2174/157488711002150714141234




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science